During the past decade, Hôpital Paule de Viguier; conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Paule de Viguier;" #1 sponsor was "University Hospital, Bordeaux" with 2 trials, followed by "ANRS, Emerging Infectious Diseases" with 1 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored, "Centre Leon Berard" with 1 trials sponsored and "French National Agency for Research on AIDS and Viral Hepatitis" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Paule de Viguier;" #1 collaborator was "INSERM, Epopé team" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "Ministry of Health, France" with 1 trials as a collaborator, "National Cancer Institute, France" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Paule de Viguier;" are "Acute Coronary Syndrome" (1 trials), "Aneuploidy" (1 trials), "CIN2/3 Recurrence" (1 trials), "Children Infected by HIV" (1 trials) and "Down Syndrome" (1 trials). Many other conditions were trialed in "Hôpital Paule de Viguier;" in a lesser frequency.

Most popular intervention types in "Hôpital Paule de Viguier;" are "Drug" (2 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bivalirudin" (1 trials), "First-trimester preeclampsia screening (FMF triple test)" (1 trials), "Heparin" (1 trials), "NON-IMMUNE HYDROPS FETALIS diagnosis" (1 trials) and "Phone interview and blood test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Paule de Viguier;" are 6 trials for "Female" genders, 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Paule de Viguier;". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hôpital Paule de Viguier;, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Paule de Viguier;, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".